Form 8-K RESMED INC For: Oct 26

Go back to Form 8-K RESMED INC For: Oct 26

ResMed (RMD) share price 'may have overcompensated' - Morgan Stanley

October 27, 2023 11:38 AM EDT

Morgan Stanley upgraded shares of ResMed (NYSE: RMD) to Overweight from Equal-Weight, lowering the price target on the stock to $169 from $180 per share in a note to clients Friday.

Analyst Sean Laaman told investors that their deep dive analysis on the obstructive sleep apnea (OSA) market suggests the... More